GLP-1 Pills Are Coming

Good news for people who are terrified of needles but interested in taking a GLP-1: Weight-loss pills are on the way. On Monday, the FDA approved a pill version of Wegovy, which will hit the market in January. More »

🐢 FDA approves first weight loss pill + 8 more stories

In the last 5 days ChatGPT read 146994 top news stories. After removing previously covered events, there are 9 articles with a significance score over 5.5. [5.5] FDA approves first GLP-1 pill for obesity — statnews.com (+77) The FDA has approved the first oral GLP-1 pill for obesity, a version of Novo Nordisk’s Wegovy, potentially […]

The Weight-Loss Drug Wegovy Now Comes in a Pill

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Wegovy pill from Novo Nordisk. The pill will contain 25 mg of semaglutide—the same compound in the […]

Seven Biopharma Trends to Watch in 2026

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last spring. Blair cited the SPDR S&P Biotech exchange-traded fund (NYSE Arca: XBI), which bounced back from $66.66 a share on April […]

Novo Nordisk Gets US Approval for Wegovy Obesity Pill

Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help […]